Retired scientists criticise safety deficiencies and regulatory oversights in pharmaceutical plant accident investigation, calling for improved standards.

Johnson & Johnson’s consumer health spinout Kenvue is quickly amassing a track record of being a target for activist ...

This is the latest sign of global healthcare giants doubling down on the market in recent years. Experts noted on Monday that ...

Novo Nordisk has quickly expanded its discounted Wegovy program, now offering all eligible cash-paying customers its popular ...

The investments come amid an ongoing investment fraud probe into AstraZeneca’s former China head Leon Wang—and despite ...

"Death of a Unicorn," writer-director Alex Scharfman's feature debut, is about just what it sounds like. Paul Rudd, Jenna ...

Tharimmune, Inc. (Nasdaq:THAR) (”Tharimmune” or the “Company”), a clinical-stage biotechnology company focused on immunology and inflammation, today announced positive preclinical results for its ...

The pet food company is pivoting to pharmaceuticals through the deal with the Canadian specialty pharmacy operator.

StockNews.com assumed coverage on shares of MEI Pharma (NASDAQ:MEIP – Free Report) in a research note released on Sunday. The brokerage issued a buy rating on the stock. MEI Pharma Stock Down 0.4 % ...

With Eli Lilly’s Mounjaro entering India, the weight-loss drug race is on. But with steep prices and generics on the way, how ...

Novo Nordisk’s hopes of heralding a new era of obesity treatment with its next-generation CagriSema drug may be in doubt ...

AstraZeneca's five-year US$2.5 billion investment, announced on Friday, includes a new research-and-development center in Beijing and a research agreement with Harbour BioMed. The U.K. firm will also ...